Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Friday 01 February, 2019

AstraZeneca PLC

Total Voting Rights

RNS Number : 8642O
AstraZeneca PLC
01 February 2019

1 February 2019 15:00 GMT


Transparency Directive

Voting Rights and Capital


The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 January 2019 the issued share capital of AstraZeneca PLC with voting rights is 1,267,101,448 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,267,101,448.


The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.



About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit and follow us on Twitter @AstraZeneca.

Media Relations



Gonzalo Viña


+44 203 7495916

Karen Birmingham


+44 203 7495634

Rob Skelding


+44 203 7495821

Matt Kent


+44 203 7495906

Jennifer Hursit


+44 203 7495762

Christina M Hägerstrand


+46 8 552 53 106

Michele Meixell


+1 302 885 2677




Investor Relations



Thomas Kudsk Larsen


+44 203 7495712

Henry Wheeler


+44 203 7495797

Christer Gruvris

BioPharma - Cardiovascular; Metabolism

+44 203 7495711

Nick Stone

BioPharma - Respiratory; Renal

+44 203 7495716

Josie Afolabi


+44 203 7495631

Craig Marks

Finance; Fixed Income

+44 7881 615764

Jennifer Kretzmann

Retail Investors; Corporate Access

+44 203 7495824

US toll-free


+1 866 381 72 77




Adrian Kemp
Company Secretary

AstraZeneca PLC


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

a d v e r t i s e m e n t